|
Index of reports
> All cases (76)
> Cases with Intra-Uterine Death (18)
Below is the selection of adverse event reports related to Erythromycin that includes all cases where reactions include intra-uterine death.
Adverse event in 28 year old female receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-26
Patient: 28 year old female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Gestational Diabetes
Suspect drug(s):
Prednisolone Sodium Phosphate
Administration route: Oral
Indication: Rosacea
Erythromycin
Administration route: Oral
Indication: Rosacea
Insulin
Indication: Gestational Diabetes
Adverse event in 28 year old female receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-25
Patient: 28 year old female
Adverse reactions / side effects: Oligohydramnios, Drug Exposure During Pregnancy, Intra-Uterine Death, Gestational Diabetes
Suspect drug(s):
Prednisolone Sodium Phosphate
Administration route: Oral
Indication: Rosacea
Erythromycin
Administration route: Oral
Indication: Rosacea
Other drugs received by patient: Insulin
Adverse event in 28 year old female receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-25
Patient: 28 year old female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Gestational Diabetes
Suspect drug(s):
Prednisolone Sodium Phosphate
Administration route: Oral
Indication: Rosacea
Erythromycin
Administration route: Oral
Indication: Rosacea
Insulin
Indication: Gestational Diabetes
Adverse event in female receiving Erythromycin
Reported by a physician from United Kingdom on 2007-07-08
Patient: female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Pregnancy
Suspect drug(s):
Prednisolone Acetate
Administration route: Oral
Indication: Rosacea
Erythromycin
Dosage: 500 mg, tid
Indication: Rosacea
Insulin
Indication: Drug USE FOR Unknown Indication
Adverse event in 28 year old female receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-03
Patient: 28 year old female
Adverse reactions / side effects: Body Mass Index Increased, Oligohydramnios, Drug Ineffective, Intra-Uterine Death, Complications of Maternal Exposure TO Therapeutic Drugs, Caesarean Section, Drug Exposure During Pregnancy, Gestational Diabetes
Suspect drug(s):
Erythromycin
Dosage: see image
Administration route: Oral
Indication: Rosacea
Prednisolone
Dosage: see image
Administration route: Oral
Indication: Rosacea
Other drugs received by patient: Dinoprostone (Dinoprostone); Mifepristone (Mifepristone); Misoprostol
Adverse event in female receiving Erythromycin
Reported by a physician from United Kingdom on 2007-06-29
Patient: female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Pregnancy
Suspect drug(s):
Prednisolone Acetate
Administration route: Oral
Indication: Rosacea
Erythromycin
Dosage: 500 mg, tid
Indication: Rosacea
Insulin
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Erythromycin
Reported by a physician from United Kingdom on 2007-06-25
Patient: female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Pregnancy
Suspect drug(s):
Prednisolone Acetate
Administration route: Oral
Indication: Rosacea
Erythromycin
Dosage: 500 mg, tid
Indication: Rosacea
Insulin
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Erythromycin
Reported by a physician from United Kingdom on 2007-06-07
Patient: female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Pregnancy
Suspect drug(s):
Prednisolone Acetate
Indication: Rosacea
Erythromycin
Dosage: 500 mg, tid
Indication: Rosacea
Insulin
Indication: Drug USE FOR Unknown Indication
Adverse event in male receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-03-01
Patient: male
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death, Stillbirth, Foetal Movements Decreased, Induced Labour, Caesarean Section, Drug Exposure During Pregnancy, NO Therapeutic Response, Foetal Arrhythmia
Adverse event resulted in: death
Suspect drug(s):
Prednisolone
Dosage: trp
Erythromycin
Dosage: 500 mg 3/d trp
Insulin
Dosage: trp
Adverse event in male receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-03-01
Patient: male
Adverse reactions / side effects: Caesarean Section, Oligohydramnios, Drug Exposure During Pregnancy, Intra-Uterine Death, Stillbirth, Erythema, Foetal Arrhythmia
Adverse event resulted in: death
Suspect drug(s):
Prednisolone
Dosage: trp
Indication: Rosacea
Erythromycin
Dosage: trp
Indication: Rosacea
Adverse event in male receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-02-20
Patient: male
Adverse reactions / side effects: Caesarean Section, Drug Exposure During Pregnancy, Intra-Uterine Death, Stillbirth, Foetal Arrhythmia
Adverse event resulted in: death
Suspect drug(s):
Prednisolone
Erythromycin
Adverse event in male receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-02-12
Patient: male
Adverse reactions / side effects: Caesarean Section, Oligohydramnios, Drug Exposure During Pregnancy, Intra-Uterine Death, Congenital Anomaly, Stillbirth, Foetal Arrhythmia
Adverse event resulted in: death
Suspect drug(s):
Erythromycin
Dosage: transplacental
Prednisolone
Other drugs received by patient: Minocycline HCL; Oxytetracycline
Adverse event in 28 year old female receiving Erythromycin
Reported by a physician from United Kingdom on 2007-02-07
Patient: 28 year old female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death
Suspect drug(s):
Prednisolone Acetate
Indication: Rosacea
Insulin
Indication: Drug USE FOR Unknown Indication
Erythromycin
Indication: Rosacea
Adverse event in 6 month old male receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-02-05
Patient: 6 month old male
Adverse reactions / side effects: Oligohydramnios, Caesarean Section, Drug Exposure During Pregnancy, Intra-Uterine Death, Foetal Arrhythmia
Adverse event resulted in: death
Suspect drug(s):
Prednisolone
Dosage: trp
Erythromycin
Dosage: 500 mg 3/d trp
Insulin
Dosage: trp
Adverse event in 28 year old female receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-01-24
Patient: 28 year old female
Adverse reactions / side effects: Caesarean Section, Oligohydramnios, Intra-Uterine Death, Stillbirth, Foetal Movements Decreased, Foetal Arrhythmia
Suspect drug(s):
Prednisolone Sodium Phosphate
Dosage: oral
Administration route: Oral
Indication: Rosacea
Erythromycin
Dosage: 500 milligrams; 3 times a day; oral
Administration route: Oral
Indication: Rosacea
Insulin
Indication: Gestational Diabetes
Other drugs received by patient: Lymecycline
Adverse event in male receiving Erythromycin
Reported by a individual with unspecified qualification from United Kingdom on 2007-01-22
Patient: male
Adverse reactions / side effects: Caesarean Section, Oligohydramnios, Drug Exposure During Pregnancy, Intra-Uterine Death
Adverse event resulted in: death
Suspect drug(s):
Prednisolone
Erythromycin
Adverse event in male receiving Erythromycin
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-01-18
Patient: male
Adverse reactions / side effects: Oligohydramnios, Drug Exposure During Pregnancy, Intra-Uterine Death, Foetal Arrhythmia
Adverse event resulted in: death
Suspect drug(s):
Prednisolone
Erythromycin
Adverse event in 28 year old female receiving Erythromycin
Reported by a physician from United Kingdom on 2007-01-15
Patient: 28 year old female
Adverse reactions / side effects: Oligohydramnios, Intra-Uterine Death
Suspect drug(s):
Prednisolone Acetate
Indication: Drug USE FOR Unknown Indication
Erythromycin
Indication: Drug USE FOR Unknown Indication
Insulin
Indication: Drug USE FOR Unknown Indication
|
